Prescription Drugs






As a long-standing partner of dermatologists, we address the main dermatological pathologies, such as acne, mycosis, psoriasis, atopical dermatitis and alopecia. It is our ambition to become a global player in pediatric dermatology, thanks in particular to the development of a specific drug to treat pediatric hemangioma.


The presence of Pierre Fabre in the field of neuropsychiatry dates back to the late 1990s, with the development of milnacipran, a molecule used to treat depression in Europe and fibromyalgia in the United States, where its enantiomer, levomilnacipran, is marketed for treating major depressive episodes.